183 related articles for article (PubMed ID: 37170791)
1. Efficacy of hematopoietic stem cell transplantation treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.
Zheng Y; Hu J; Sun C; Zhao C; Lin J
Eur J Neurol; 2023 Aug; 30(8):2570-2582. PubMed ID: 37170791
[TBL] [Abstract][Full Text] [Related]
2. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
3. Progress in Hematopoietic Stem Cell Transplantation for CIDP.
Qin Z; Huang Q; Zou J; Tang L; Hu Z; Tang X
Int J Med Sci; 2020; 17(2):234-241. PubMed ID: 32038107
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
Kazmi MA; Mahdi-Rogers M; Sanvito L
Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
Bright RJ; Wilkinson J; Coventry BJ
BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
Kaplan A; Brannagan TH
Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
Peltier AC; Donofrio PD
Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F; van Schaik IN
Expert Opin Biol Ther; 2008 May; 8(5):643-55. PubMed ID: 18407767
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.
Hu J; Sun C; Lu J; Zhao C; Lin J
J Neurol; 2022 Mar; 269(3):1250-1263. PubMed ID: 34120208
[TBL] [Abstract][Full Text] [Related]
11. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
[TBL] [Abstract][Full Text] [Related]
12. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Shije J; Brannagan TH
Semin Neurol; 2019 Oct; 39(5):596-607. PubMed ID: 31639843
[TBL] [Abstract][Full Text] [Related]
13. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
14. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
Hughes R; Dalakas MC; Merkies I; Latov N; Léger JM; Nobile-Orazio E; Sobue G; Genge A; Cornblath D; Merschhemke M; Ervin CM; Agoropoulou C; Hartung HP;
Lancet Neurol; 2018 Aug; 17(8):689-698. PubMed ID: 30001923
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation for uncommon immune-mediated neurological disorders: A literature review.
Jaime-Pérez JC; Meléndez-Flores JD; Ramos-Dávila EM; González-Treviño M; Gómez-Almaguer D
Cytotherapy; 2022 Jul; 24(7):676-685. PubMed ID: 35193829
[TBL] [Abstract][Full Text] [Related]
16. Advances in the diagnosis, pathogenesis and treatment of CIDP.
Dalakas MC;
Nat Rev Neurol; 2011 Aug; 7(9):507-17. PubMed ID: 21844897
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
Iijima M; Koike H; Sobue G
Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
[TBL] [Abstract][Full Text] [Related]
18. Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation.
Vogl U; Leitner G; Dal-Bianco A; Bojic M; Mitterbauer M; Rabitsch W; Kalhs P; Schulenburg A
Wien Klin Wochenschr; 2016 May; 128(9-10):384-6. PubMed ID: 26919852
[TBL] [Abstract][Full Text] [Related]
19. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
Svačina MKR; Lehmann HC
Curr Pharm Des; 2022; 28(11):854-862. PubMed ID: 35339172
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy.
Burt RK; Balabanov R; Tavee J; Han X; Sufit R; Ajroud-Driss S; Jovanovic B; Quigley K; Arnautovic I; Helenowski I; Sharrack B
J Neurol; 2020 Nov; 267(11):3378-3391. PubMed ID: 32594300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
